Prognostic DNA Methylation Markers for Prostate Cancer

por Strand, Siri H., Orntoft, Torben F., Sorensen, Karina D.
Publicado 2014

Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling

por Schepeler, Troels, Mansilla, Francisco, Christensen, Lise L, Ørntoft, Torben F, Andersen, Claus L
Publicado 2007

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer

por Zieger, Karsten, Wiuf, Carsten, Jensen, Klaus Møller-Ernst, Ørntoft, Torben Falck, Dyrskjøt, Lars
Publicado 2009

Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case–control study

por Ørntoft, Mai-Britt W., Nielsen, Hans J., Ørntoft, Torben F., Andersen, Claus L.
Publicado 2015

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation

por Reinert, Thomas, Borre, Michael, Christiansen, Anders, Hermann, Gregers G., Ørntoft, Torben F., Dyrskjøt, Lars
Publicado 2012

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer

por Laurberg, Jens Reumert, Jensen, Jørgen Bjerggaard, Schepeler, Troels, Borre, Michael, Ørntoft, Torben F, Dyrskjøt, Lars
Publicado 2014

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy

por Mortensen, Martin Mørck, Høyer, Søren, Ørntoft, Torben Falck, Sørensen, Karina Dalsgaard, Dyrskjøt, Lars, Borre, Michael
Publicado 2014

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder

por Herbsleb, Malene, Christensen, Ole F, Thykjaer, Thomas, Wiuf, Carsten, Borre, Michael, Ørntoft, Torben F, Dyrskjøt, Lars
Publicado 2008

A Beta-mixture model for dimensionality reduction, sample classification and analysis

por Laurila, Kirsti, Oster, Bodil, Andersen, Claus L, Lamy, Philippe, Orntoft, Torben, Yli-Harja, Olli, Wiuf, Carsten
Publicado 2011

Construction and validation of the APOCHIP, a spotted oligo-microarray for the study of beta-cell apoptosis

por Magnusson, Nils E, Cardozo, Alessandra K, Kruhøffer, Mogens, Eizirik, Decio L, Ørntoft, Torben F, Jensen, Jens L
Publicado 2005

Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells

por Herbsleb, Malene, Birkenkamp-Demtroder, Karin, Thykjaer, Thomas, Wiuf, Carsten, Hein, Anne-Mette K, Ørntoft, Torben F, Dyrskjøt, Lars
Publicado 2008

Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs

por Jensen, Steffen G, Lamy, Philippe, Rasmussen, Mads H, Ostenfeld, Marie S, Dyrskjøt, Lars, Ørntoft, Torben F, Andersen, Claus L
Publicado 2011

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy

por Mortensen, Martin Mørck, Høyer, Søren, Lynnerup, Anne-Sophie, Ørntoft, Torben Falck, Sørensen, Karina Dalsgaard, Borre, Michael, Dyrskjøt, Lars
Publicado 2015

Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study

por Kirkegaard, Pia, Edwards, Adrian, Nielsen, Trine Laura Overgaard, Ørntoft, Torben Falck, Sørensen, Karina Dalsgaard, Borre, Michael, Bro, Flemming
Publicado 2018

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression

por Egerod, Frederikke Lihme, Bartels, Annette, Fristrup, Niels, Borre, Michael, Ørntoft, Torben F, Oleksiewicz, Martin B, Brünner, Nils, Dyrskjøt, Lars
Publicado 2009

Keratin23 (KRT23) Knockdown Decreases Proliferation and Affects the DNA Damage Response of Colon Cancer Cells

por Birkenkamp-Demtröder, Karin, Hahn, Stephan A., Mansilla, Francisco, Thorsen, Kasper, Maghnouj, Abdelouahid, Christensen, Rikke, Øster, Bodil, Ørntoft, Torben Falck
Publicado 2013

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

por Storebjerg, Tine Maj, Strand, Siri H., Høyer, Søren, Lynnerup, Anne-Sofie, Borre, Michael, Ørntoft, Torben F., Sørensen, Karina D.
Publicado 2018

epiG: statistical inference and profiling of DNA methylation from whole-genome bisulfite sequencing data

por Vincent, Martin, Mundbjerg, Kamilla, Skou Pedersen, Jakob, Liang, Gangning, Jones, Peter A., Ørntoft, Torben Falck, Dalsgaard Sørensen, Karina, Wiuf, Carsten
Publicado 2017

Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies

por Haldrup, Christa, Pedersen, Anne L., Øgaard, Nadia, Strand, Siri H., Høyer, Søren, Borre, Michael, Ørntoft, Torben F., Sørensen, Karina D.
Publicado 2018

The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial

por Fredsøe, Jacob, Koetsenruyter, Jan, Vedsted, Peter, Kirkegaard, Pia, Væth, Michael, Edwards, Adrian, Ørntoft, Torben F., Sørensen, Karina D., Bro, Flemming
Publicado 2020